Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

ENTREMED INC
Mes dernières consult.
Most popular
SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Zuie Chin Huang, MBA522013Independent Director
Yue Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
James E. Goldschmidt, PhD-2016Vice President-Business Development
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 28,808,916 47.8% 79,545 0.1% 47.8%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 5,452,385 9.06%
Zhejiang Kanglaite Group Co. Ltd. 4,938,269 8.20%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 726,069 1.21%
Wellington Shields & Co. LLC (Investment Management) 505,474 0.84%
European & Global Advisers LLP 343,500 0.57%
The Vanguard Group, Inc. 287,890 0.48%
BlackRock Fund Advisors 282,036 0.47%
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC111
INCYTE CORPORATION14.56%24 235
QUINTILES IMS HOLDINGS INC24.44%20 267
LONZA GROUP57.01%19 853
CELLTRION, INC.--.--%15 738
ALNYLAM PHARMACEUTICALS, INC.204.06%10 359
ALKERMES PLC-8.85%7 735
SEATTLE GENETICS, INC.0.13%7 489
QIAGEN NV9.53%7 357
IONIS PHARMACEUTICALS INC12.65%6 445
ICON PLC48.51%6 035
EXACT SCIENCES CORPORATION224.85%5 359
GALAPAGOS38.86%5 149
UNITED THERAPEUTICS CORPORATION-18.03%5 015
CHARLES RIVER LABORATORIES INTL. INC38.86%5 015
PRA HEALTH SCIENCES INC37.21%4 741
ACADIA PHARMACEUTICALS INC.27.77%4 606
BIO-TECHNE CORP17.91%4 532
PAREXEL INTERNATIONAL CORPORATION33.90%4 498
FIBROGEN INC147.20%4 177
PUMA BIOTECHNOLOGY INC247.88%3 899
Connections : EntreMed Inc
Shrotriya Family Foundation
Circle Internet Financial Ltd.
Wuhan Kindstar Diagnostics Co., Ltd.
ImmunoVentis, Inc.
Human Longevity, Inc.
Emerging Technology Partners LLC
CVie Therapeutics Co. Ltd.
IDG Technology Venture Investment, Inc.
Zenesis Ltd.
IDG Capital Partners Co., Ltd.
OMNI Pharmaceuticals (USA), Inc.
American-Sino OB/GYN Hospital
Smooth Prosper Ltd.
The UNLV Foundation
GenScript Corp.
Cs Family Trust
KPCB China Fund II LP
OriGene Technologies, Inc.
IDG Technology Venture Investment IV LLC
MithraGen, Inc.
Superdata Software Holdings Ltd.
WUPIMA, Inc.
Intradigm Corp.
Creditease Holdings Cayman Ltd.
Allos Therapeutics, Inc.
MZ Investment Holdings Ltd.
Beijing Genetron Biotechnology Co. Ltd.
IDG Technology Venture Investment III LLC
National Foundation for Cancer Research
IDG Technology Venture Investments LP
© 2017 People , Fundamentals and Ownership